PR Newswire
Conference Call to be Held on November 10, 2022
RANCHO CORDOVA, Calif. , Nov. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will release its financial results for the third quarter ended September 30, 2022 , and provide a corporate strategic update on Thursday, November 10, 2022 . A conference call and webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET .
To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 ( Canada ). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts/ .
A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com .
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com .
Company Contact: Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact: Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
SOURCE ThermoGenesis Holdings, Inc.